Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo

International Journal of Dermatology

Volumn 41, Issue 10, 2002, Pages 640-642

  Boisseau Garsaud, Anne Marie ^a   Garsaud, Philippe ^b   Lejoly Boisseau, Hélène ^b   Robert, Michel ^b   Quist, Danielle ^b   Arveiler, Benoît ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CATALASE; CERULOPLASMIN; FERRITIN; HYDROGEN PEROXIDE; RETINOL; SELENIUM; TOCOPHEROL; TRANSFERRIN;

ADULT; AGED; BLOOD LEVEL; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DEVICE; EPIDERMIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; MALE; MELANOCYTE; NEGRO; OXIDATIVE STRESS; TRANSFERRIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; VITILIGO;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTIOXIDANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SELENIUM; SKIN PIGMENTATION; VITILIGO;

EID: 0036774904     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01472.x     Document Type: Conference Paper

References (27)

1. Boisseau-Garsaud AM, Garsaud P, Calès-Quist D, et al. Epidemiology of vitiligo in the French West Indies (Isle of Martinique). Int J Dermatol 2000; 39: 18-20.
2. Das SK, Majumder PP, Chakraborty R, et al. Studies on vitiligo. I. Epidemiologic profiles in Calcutta, India. Genet Epidemiol 1985; 24: 233-387.
3. Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113; 47-52.
4. Le Poole IC, Das PK, Van den Wijngaard RM, et al. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993; 2: 145-153.
5. Maresca V, Roccella M, Roccella F, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997; 109: 310-313.
6. Tobin DJ, Swanson NN, Pittelkow MR, et al. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol 2000; 191: 407-416.
7. Passi S, Grandinetti M, Maggio F, et al. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998; 11: 81-85.
8. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Invest Dermatol Symp Proc 1999; 4: 91-96.
9. Beazley WD, Gaze D, Panske A, et al. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999; 141: 301-303.
10. Fitzpatrick TB. Sunlight and Man. Tokyo: University of Tokyo Press, 1974.
11. Picardo M, Passi S, Morrone A, et al. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994; 7: 110-115.
12. Bowers RR, Nguyen B, Buckner S, et al. Role of antioxidants in the survival of normal and vitiliginous avian melanocytes. Cell Mol Biol 1999; 45: 1065-1074.
13. Morrone A, De Picardo M, Luca C, et al. Catecholamines and vitiligo. Pigment Cell Res 1992; 5: 65-69.
14. Yohn JJ, Norris DA, Yrestorza DG, et al. Disparate antioxidant system activities in cultured human cutaneous fibroblasts, keratinocytes and melanocytes. J Invest Dermatol 1991; 97: 405-409.
15. Bhawan J, Bhutani LK. Keratinocytes damage in vitiligo. J Cutan Pathol 1983; 10: 207-212.
16. Moellmann G, Klein-Angerer S, Scollay DA, et al. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 1982; 79: 321-330.
17. Calanchini-Postizzi E, Frenk E. Long term actinic damage in sun exposed vitiligo and normally pigmented skin. Dermatologica 1987; 174: 266-271.
18. Schallreuter KU, Pittelkow MR, Wood JM. Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes. J Invest Dermatol 1986; 87: 728-732.
19. Schallreuter KU, Hordinsky MK, Wood JM. Thioredoxin reductase: free radical reduction by thioredoxin reductase on the skin of different hypopigmentation disorders. Arch Dermatol 1987; 123: 615-619.
20. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991; 97: 1081-1085.
21. Halliwell B, Gutteridge JMC. Ischemia/reoxygenation injury. In: Halliwell B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine, 2nd edn. Oxford: Clarendon Press, 1989: 438-447.
22. Teherani DK, Nagy-Vezekenyi K. Neutron activation analysis of some trace elements (selenium, chromium, cobalt and nickel) in the blood of vitiligo patients. J Radioanal Nucl Chem 1986; 104: 53-58.
23. Friedl HP, Till GO, Ward PA. Roles of histamine, complement and xanthine oxidase in thermal injury of the skin. Am J Pathol 1989; 135: 203-217.
24. McCord JM. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed Proc 1987; 46: 2402-2406.
25. Pence BC, Naylor MF. Effects of a single dose of ultraviolet radiation on skin superoxide dismutase, catalase and xanthine oxidase in hairless mouse. J Invest Dermatol 1990; 95: 213-216.
26. Lerner A. On the etiology of vitiligo and gray hair. Am J Med 1971; 51: 141-147.
27. Schallreuter KU, Wood JM. Free radical reduction in the human epidermis. Free Rad Biol Med 1989; 6: 519-532.